Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

181 recalls, newest first

Class II · Moderate risk

Estriol 8 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1421-2020
Class II · Moderate risk

Estriol 6 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1420-2020
Class II · Moderate risk

D-Biotin 300 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1419-2020
Class II · Moderate risk

Lidothol Patch

CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. D-1390-2020
Class III · Low risk

Tecfidera (dimethyl fumarate)

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Terminated cGMP deviation Biogen MA Inc. NDC 64406-006-02 D-1381-2020
Class II · Moderate risk

Levothyroxin

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1228-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1218-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1217-2020
Class II · Moderate risk

Bi-Est

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1216-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1215-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1214-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1213-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1212-2020

Recalls by year